IP Library Granted Patent US 11,197,754
Granted Patent B2
US 11,197,754 · App. 16/481,287 · Granted Dec 14, 2021

Heart valve mimicry

Inventors: Payam Saffari (Aliso Viejo, CA); Vincent Ming Hai Chow (Irvine, CA); Makensley Lordeus (Costa Mesa, CA); Hussain S. Rangwala (Villa Park, CA); Gregory Edwin Mirigian (Dublin, CA); John F. Migliazza (Irvine, CA); Victoria E. Carr-Brendel (Irvine, CA)
Assignee: JenaValve Technology, Inc.
A61F2/2418A61B17/0401A61F2/2415A61F2220/0008A61F2220/0016A61F2220/0075A61F2250/0039A61F2250/0097
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,197,754
App. No.
16/481,287
Granted
Dec 14, 2021
Kind
B2
Abstract

The disclosure relates to a heart valve with improved functionality and durability.

Claims (35)

1. A replacement heart valve prosthesis comprising a stent component and a valve component, wherein:

the valve component has a valve ratio of annulus to commissure distance (ACD) to annulus diameter (AD) of 1.01 to 1.14, the ACD being a distance between a proximal end of a commissure portion and a proximal end of an annulus portion; and

the stent component comprises an inflow end region and an outflow end region each comprising a plurality of cells, wherein in the inflow end region, a ratio of area of a given cell to a neighboring cell is 0.25 to 4, a ratio of height of the given cell to the neighboring cell is 0.5 to 2, or an aspect ratio of all cells of the inflow end region is 1 to 2, and wherein in the outflow end region, aspect ratios of a first cell and a second cell in a single circumferential row vary with respect to one another from 1 to 3, areas of the first cell and the second cell vary with respect to one another from 5 mm 2 to 250 mm 2 , or heights of the first cell and the second cell vary with respect to one another from 3 mm to 30 mm.

2. The prosthesis according to claim 1 , wherein the stent component includes at least one feeler for aligning the stent component relative to a native heart valve.

3. The prosthesis according to claim 2 , wherein the at least one feeler is configured to be introduced into a native cusp of the native heart valve.

4. The prosthesis according to claim 3 , wherein a distance from a proximal end of the at least one feeler to a distal end of the inflow end region of the stent component is 4 mm to 12 mm.

5. The prosthesis according to claim 4 , wherein the distance from the proximal end of the at least one feeler to the distal end of the inflow end region is 7.5 mm to 9 mm.

6. The prosthesis according to claim 2 , wherein the stent component includes three feelers for aligning the stent component relative to native cusps of the native heart valve.

7. The prosthesis according to claim 1 , wherein the valve component comprises tissue, and the stent component further comprises an arch for fixation of the valve tissue.

8. The prosthesis according to claim 7 , wherein the valve tissue comprises pericardial tissue.

9. The prosthesis according to claim 7 , wherein the arch comprises holes, rails, or notches.

10. The prosthesis according to claim 1 , wherein the valve ratio of ACD to AD is 1.03 to 1.04.

11. The prosthesis according to claim 1 , wherein a number of cells per cm 2 area of the stent component is 2 to 6 in the inflow end region, and 1 to 4 in the outflow end region.

12. The prosthesis according to claim 11 , wherein the number of cells per cm 2 area of the inflow end region is 3.7 to 5.1.

13. The prosthesis according to claim 11 , wherein the number of cells per cm 2 area of the outflow end region is 1.9 to 2.5.

14. The prosthesis according to claim 1 , wherein, in the inflow end region:

the ratio of area of the given cell to the neighboring cell is 1;

the ratio of height of the given cell to the neighboring cell is 1; and

the aspect ratio of all cells of the inflow end region is 1.5 to 1.6.

15. The prosthesis according to claim 1 , wherein, in the outflow end region:

the aspect ratios of the first cell and the second cell vary from 1.1 to 2.9;

the areas of the first cell and the second cell vary from 7 mm 2 to 198 mm 2 ; and

the heights of the first cell and the second cell vary from 6 mm to 25 mm.

16. The prosthesis according to claim 1 , wherein the prosthesis has a radial force, wherein 15 to 25% of the radial force is provided by an annulus region, and 75 to 85% of the radial force is provided by a supra-annulus region.

17. A replacement heart valve prosthesis comprising a stent component and a valve component, wherein:

the valve component has a valve ratio of annulus to commissure distance (ACD) to annulus diameter (AD) of 1.01 to 1.14, the ACD being a distance between a proximal end of a commissure portion and a proximal end of an annulus portion; and

the stent component comprises:

an inflow end region and an outflow end region each comprising a plurality of cells, a number of cells per cm 2 area being 2 to 6 in the inflow end region and 1 to 4 in the outflow end region; and

at least one feeler configured to engage with a native commissure of a native heart valve, the at least one feeler being part of, or fixed to, a proximal end of the prosthesis.

18. A method for treating heart valve stenosis or heart valve insufficiency comprising

introducing a catheter preloaded with the prosthesis according to claim 1 in a patient's vasculature,

positioning the catheter for deploying the prosthesis at a target site,

releasing and deploying the prosthesis at the target site, and

retracting the catheter from the patient's vasculature.

19. The method of claim 18 , further comprising loading the prosthesis into the catheter before the step of introducing the catheter in the patient's vasculature.

Assignments (2)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 28, 2022
From: JENAVALVE TECHNOLOGY, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058894/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: SAFFARI, PAYAM; CHOW, VINCENT MING HAI; LORDEUS, MAKENSLEY; RANGWALA, HUSSAIN R.; MIRIGIAN, GREGORY EDWIN; MIGLIAZZA, JOHN F.; CARR-BRENDEL, VICTORIA E.
To: JENAVALVE TECHNOLOGY, INC.
Reel/Frame 057360/0106 →
Cited By (21)
US 12,318,281 US 12,318,289 US 12,324,736 US 12,343,255 US 12,414,854 US 12,433,745 US 12,453,630 US 12,514,701 US 12,544,226 US 12,569,336 US 12,582,520 US 12,588,988 US 12,588,989 US 12,588,998 US 12,594,164 US 12,599,481 US 12,616,593 US 12,636,146 US 12,636,148 US 12,640,270 US 12,642,650